Figure 2From: Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data Effects of Sensitivity Analysis on the Incremental Cost Effectiveness Ratio Estimates for the Model.Back to article page